Clinical trial
Allopurinol for Renal Transplant Associated Hypertension in Children
NCT00288171 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Withdrawn
Key facts
| NCT number | NCT00288171 |
|---|---|
| Title | Allopurinol for Renal Transplant Associated Hypertension in Children |
| Official title | Randomized Double-blinded, Placebo-controlled, Cross-over Trial of Allopurinol for the Treatment of Post-renal-transplant Hypertension in Children |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Baylor University |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension, Renal Transplant |
| Intervention type | Drug |
| Interventions | Placebo, Allopurinol |
| Enrollment | 0 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 7, 2006 |
| Last update posted | Sep 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: